N6-methyladenosine ALKBH5 promotes non-small cell lung cancer progress by regulating TIMP3 stability

Jan 14, 2020Gene

How ALKBH5 helps non-small cell lung cancer grow by controlling the stability of TIMP3

AI simplified

Abstract

ALKBH5 is ectopically up-regulated in non-small cell lung cancer (NSCLC) tissue and cells.

  • ALKBH5 expression is closely correlated with poor prognosis in NSCLC patients.
  • ALKBH5 promotes proliferation and reduces apoptosis of NSCLC cells in laboratory settings.
  • Knockdown of ALKBH5 inhibits tumor growth in live models.
  • ALKBH5 targets TIMP3, affecting its mRNA stability and protein production.
  • The study confirms the role of the ALKBH5/TIMP3 pathway in NSCLC development.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free